Literature DB >> 29567349

Whole exome sequencing discloses a pathogenic MTM1 gene mutation and ends the diagnostic odyssey in an older woman with a progressive and seemingly sporadic myopathy: Case report and literature review of MTM1 manifesting female carriers.

Kevin J Felice1, Charles H Whitaker2, Qian Wu3.   

Abstract

We report the case of a 58-year-old woman with a progressive and seemingly sporadic myopathy who, later through whole exome sequencing, was diagnosed as a manifesting carrier of a myotubularin 1 gene mutation (c.342_342 + 4delAGTAA). As the case was a diagnostic challenge for 7 years, we thought it would be helpful to report the patient and review the other 25 cases thus far described. The manifesting carrier state is a rare cause for myopathic weakness in a female but should be strongly considered in kindreds with known affected males with myotubularin 1 gene mutations, and families with history of gestational polyhydramnios or male infantile death. Although the clinical phenotype is quite variable, the findings of ptosis, ophthalmoparesis, facial weakness, and asymmetrical limb involvement should raise the suspicion of the manifesting carrier state. Necklace fibers appear to be a highly sensitive and specific pathologic finding in such cases.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Centronuclear myopathies; Congenital myopathies; MTM1; Manifesting female carriers; Necklace fibers

Mesh:

Substances:

Year:  2018        PMID: 29567349     DOI: 10.1016/j.nmd.2018.02.002

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  1 in total

1.  Spectrum of Clinical Features in X-Linked Myotubular Myopathy Carriers: An International Questionnaire Study.

Authors:  Stacha F I Reumers; Frederik Braun; Jennifer E Spillane; Johann Böhm; Maartje Pennings; Meyke Schouten; Anneke J van der Kooi; A Reghan Foley; Carsten G Bönnemann; Erik-Jan Kamsteeg; Corrie E Erasmus; Ulrike Schara-Schmidt; Heinz Jungbluth; Nicol C Voermans
Journal:  Neurology       Date:  2021-05-19       Impact factor: 11.800

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.